BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON Share Price

Certificat

JR71S

DE000SQ8JB03

Real-time Euronext Paris 14:28:54 16/07/2024 BST
7.258 EUR +0.22% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON
Current month+4.08%
1 month+6.63%
Date Price Change
16/07/24 7.258 +0.22%
15/07/24 7.242 -1.86%
12/07/24 7.379 -0.23%
11/07/24 7.396 +4.15%
10/07/24 7.101 +4.56%

Real-time Euronext Paris

Last update July 16, 2024 at 02:28 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
JR71S
ISINDE000SQ8JB03
Date issued 01/02/2023
Strike 110.3 $
Maturity Unlimited
Parity 5 : 1
Emission price 11.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.47
Lowest since issue 6.451
Spread 0.097
Spread %1.33%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
149.2 USD
Average target price
171.5 USD
Spread / Average Target
+14.91%
Consensus
  1. Stock Market
  2. Certificates
  3. JR71S Certificat